Complication risk despite preventive endoscopic measures in patients undergoing endoscopic mucosal resection of large duodenal adenomas.


Journal

Endoscopy
ISSN: 1438-8812
Titre abrégé: Endoscopy
Pays: Germany
ID NLM: 0215166

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 15 4 2020
medline: 16 2 2021
entrez: 15 4 2020
Statut: ppublish

Résumé

BACKGROUND : Endoscopic mucosal resection (EMR) is the standard treatment of ampullary and nonampullary duodenal adenomas. EMR of large (10-29 mm) and giant (≥ 30 mm) lesions carries a risk of complications such as delayed bleeding and perforation. Prospective data on duodenal EMR are scarce. This study aimed to evaluate the efficacy of endoscopic procedures (clipping and coagulation of visible vessels) to prevent complications after EMR of large and giant lesions. METHODS : 110 patients with 118 adenomas (29 ampullary and 89 nonampullary) were included prospectively. RESULTS : 15 lesions were small (12.7 %), 68 were large (57.6 %), and 35 were giant (29.7 %). Endoscopic prevention of delayed complications was performed in 81.4 % (n = 96) of all lesions and 94.3 % (n = 33) of giant lesions. Complete resection was achieved in 111 lesions (94.1 %). Complications were 22 delayed bleedings (18.6 %), 3 intraprocedural perforations (2.5 %), 2 delayed perforations (1.7 %), and 1 stricture (0.8 %). Major complications were associated with lesions size ≥ 30 mm (28.6 % vs. 9.6 %;

Identifiants

pubmed: 32289854
doi: 10.1055/a-1144-2767
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

847-855

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Auteurs

Andreas Probst (A)

Department of Gastroenterology, University Hospital Augsburg, Augsburg, Germany.

Simone Freund (S)

Department of Gastroenterology, University Hospital Augsburg, Augsburg, Germany.

Lukas Neuhaus (L)

Department of Gastroenterology, University Hospital Augsburg, Augsburg, Germany.

Alanna Ebigbo (A)

Department of Gastroenterology, University Hospital Augsburg, Augsburg, Germany.

Georg Braun (G)

Department of Gastroenterology, University Hospital Augsburg, Augsburg, Germany.

Stefan Goelder (S)

Department of Gastroenterology, University Hospital Augsburg, Augsburg, Germany.

Tobias Weber (T)

Department of Gastroenterology, University Hospital Augsburg, Augsburg, Germany.

Bruno Märkl (B)

Institute of Pathology, University Hospital Augsburg, Augsburg, Germany.

Matthias Anthuber (M)

Department of General, Visceral and Transplantation Surgery, University Hospital Augsburg, Augsburg, Germany.

Helmut Messmann (H)

Department of Gastroenterology, University Hospital Augsburg, Augsburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH